Severity
Low
FDA Drug recall · Reported August 16, 2023
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
B. Braun Medical Inc. recalled 0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medic… - a low-severity action.
0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medic… was recalled by B. Braun Medical Inc. in August 16, 2023. Reason: Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use …. Check the official notice for the remedy. Verify recall #D-1083-2023 with the FDA Drug before acting.
The recall
B. Braun Medical Inc. issued this low-severity FDA Drug recall-Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use ….
Sourced from official FDA Drug enforcement records. Verify recall #D-1083-2023 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1083-2023) was formally reported on August 16, 2023, with the manufacturer initiating the action on August 2, 2023. It is classified under Low severity (Class III), with a current status of Terminated. B. Braun Medical Inc. is listed as the recalling firm, operating out of Daytona Beach, FL. Federal records list the affected scope as 43,812 bags.
The documented reason for this recall is: Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed. Distribution data in the federal record shows the product reached: United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
43,812 bags
Related Recalls
6
5 from same agency
0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1083-2023 |
| Date reported | August 16, 2023 |
| Date initiated | August 2, 2023 |
| Recalling firm | B. Braun Medical Inc. |
| Firm location | Daytona Beach, FL |
| Affected scope | 43,812 bags |
| Distribution | United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 16, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.